EUVIMEDEUVIMED entdecken
Crossref

Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase−1 mediated microglial pyroptosis via downregulating KLF4

Liufang He, Tingyan Wei, Hang Yin, Yuanxia Yang, Zhili Zhao, Huazhen Liu, Zhangxing Wang

Experimental Brain Research · 2026

DOI: 10.1007/s00221-026-07398-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Brain Research, 2026. Verfasst von Liufang He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, People's Hospital of Longhua, No.38 Jinglong Construction Road, Shenzhen, 518109, China. heliufang6873@163.com. Hauptthemen laut MEDLINE: Microglia, Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Rosiglitazone. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaPyroptosisNLR Family, Pyrin Domain-Containing 3 ProteinRosiglitazoneWhite MatterKruppel-Like Transcription FactorsKruppel-Like Factor 4AnimalsRatsDown-RegulationHumansPPAR-gamma AgonistsRats, Sprague-DawleyMaleCaspase 1

Stichwörter der Autor:innen

KLF4Microglial pyroptosisNLRP3RosiglitazoneWhite matter injury

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinRosiglitazoneKruppel-Like Factor 4PPAR-gamma AgonistsKruppel-Like Transcription FactorsKlf4 protein, ratNlrp3 protein, ratCaspase 1

Autor:innen und Institutionen

  • Department of Neonatology, People's Hospital of Longhua, No.38 Jinglong Construction Road, Shenzhen, 518109, China. heliufang6873@163.com.
  • Department of Neonatology, People's Hospital of Longhua, No.38 Jinglong Construction Road, Shenzhen, 518109, China.
  • Department of Pharmacy, People's Hospital of Longhua, No.38 Jinglong Construction Road, Shenzhen, 518109, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. No, 111 Dade Road, Guangzhou City, 511400, China. hz.liu@gzucm.edu.cn.
  • Department of Neonatology, People's Hospital of Longhua, No.38 Jinglong Construction Road, Shenzhen, 518109, China. wzx776@163.com.

Förderung

  • Shenzhen Science and Technology Program

Zitieren

APA

He, L., Wei, T., Yin, H., Yang, Y., Zhao, Z., Liu, H., & Wang, Z. (2026). Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase−1 mediated microglial pyroptosis via downregulating KLF4. Experimental Brain Research. https://doi.org/10.1007/s00221-026-07398-4

Vancouver

He L, Wei T, Yin H, Yang Y, Zhao Z, Liu H, et al. Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase−1 mediated microglial pyroptosis via downregulating KLF4. Experimental Brain Research. 2026. doi:10.1007/s00221-026-07398-4

BibTeX
@article{He2026,
  author = {He, Liufang and Wei, Tingyan and Yin, Hang and Yang, Yuanxia and Zhao, Zhili and Liu, Huazhen and Wang, Zhangxing},
  title = {Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase−1 mediated microglial pyroptosis via downregulating KLF4},
  journal = {Experimental Brain Research},
  year = {2026},
  doi = {10.1007/s00221-026-07398-4}
}
Kostenlos starten →